Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4–NF-κB signaling
Author:
Funder
Ministry of Education, Culture, Sports, Science & Technology
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference48 articles.
1. Heparin-based nanoparticles;Kemp;Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.,2010
2. Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles;Chauvierre;Pharm. Res.,2003
3. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system;Passirani;Life Sci.,1998
4. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate);Passirani;Pharm. Res.,1998
5. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity;Park;J. Control. Release,2006
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review on multifaceted biomedical applications of heparin nanocomposites: Progress and prospects;International Journal of Biological Macromolecules;2024-03
2. Extracellular matrix component-derived nanoparticles for drug delivery and tissue engineering;Journal of Controlled Release;2023-08
3. Pharmacology of Heparin and Related Drugs: An Update;Pharmacological Reviews;2023-02-15
4. Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer;Biomedicine & Pharmacotherapy;2022-12
5. Low Molecular Weight Heparin Improves the Inflammatory State of Acute Sinusitis Rats Through Inhibiting the TLR4-MyD88-NF-κB Signaling Pathway;Frontiers in Pharmacology;2021-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3